282 related articles for article (PubMed ID: 2565997)
1. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
van der Heijde DM; van Riel PL; Nuver-Zwart IH; Gribnau FW; vad de Putte LB
Lancet; 1989 May; 1(8646):1036-8. PubMed ID: 2565997
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.
Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM
Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034
[TBL] [Abstract][Full Text] [Related]
3. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine.
van der Heijde DM; van Riel PL; van de Putte LB
Scand J Rheumatol; 1990; 19(6):407-12. PubMed ID: 1979687
[TBL] [Abstract][Full Text] [Related]
5. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
[TBL] [Abstract][Full Text] [Related]
6. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
Pullar T; Hunter JA; Capell HA
Ann Rheum Dis; 1987 May; 46(5):398-402. PubMed ID: 2884932
[TBL] [Abstract][Full Text] [Related]
7. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
[TBL] [Abstract][Full Text] [Related]
8. Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine.
van der Heijde DM; van Riel PL; Nuver-Zwart IH; van de Putte LB
J Rheumatol; 2000 Feb; 27(2):535-8; discussion 538-9. PubMed ID: 10685829
[TBL] [Abstract][Full Text] [Related]
9. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
10. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
[TBL] [Abstract][Full Text] [Related]
11. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
12. Assessing the progression of joint damage in rheumatoid arthritis.
Scott DL; Farr M
Drugs; 1986; 32 Suppl 1():63-70. PubMed ID: 2877856
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.
Salaffi F; Carotti M; Cervini C
Clin Rheumatol; 1995 Jul; 14(4):458-63. PubMed ID: 7586985
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up.
van der Heijde DM; van Riel PL; Nuver-Zwart IH; van de Putte LB
Lancet; 1990 Mar; 335(8688):539. PubMed ID: 1968547
[No Abstract] [Full Text] [Related]
15. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
[TBL] [Abstract][Full Text] [Related]
16. Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.
Paulus HE; Oh M; Sharp JT; Gold RH; Wong WK; Park GS; Bulpitt KJ;
Arthritis Rheum; 2004 Apr; 50(4):1083-96. PubMed ID: 15077290
[TBL] [Abstract][Full Text] [Related]
17. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
[TBL] [Abstract][Full Text] [Related]
18. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
19. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
Pullar T; Hunter JA; Capell HA
Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1102-4. PubMed ID: 6138117
[TBL] [Abstract][Full Text] [Related]
20. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
